Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans
Corresponding Author
Kathleen F. Carlson M.S., Ph.D.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Oregon Health and Science University - Portland State University School of Public Health, Portland, OR
Address correspondence to Kathleen F. Carlson, M.S., Ph.D., HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System (R&D 66), 3710 SW US Veterans Hospital Road, Portland, OR 97239; and Oregon Health and Science University - Portland State University School of Public Health, Portland, OR; e-mail: [email protected].Search for more papers by this authorTess A. Gilbert M.H.S.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Search for more papers by this authorBenjamin J. Morasco Ph.D.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Department of Psychiatry, Oregon Health and Science University, Portland, OR
Search for more papers by this authorDagan Wright Ph.D., M.S.P.H.
Oregon Health and Science University - Portland State University School of Public Health, Portland, OR
OCHIN, Portland, OR
Search for more papers by this authorJoshua Van Otterloo M.S.P.H.
Prescription Drug Monitoring Program, Public Health Division, Oregon Health Authority, Portland, OR
Search for more papers by this authorAldona Herrndorf M.P.H.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Search for more papers by this authorLawrence J. Cook M.Stat., Ph.D.
Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT
Search for more papers by this authorCorresponding Author
Kathleen F. Carlson M.S., Ph.D.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Oregon Health and Science University - Portland State University School of Public Health, Portland, OR
Address correspondence to Kathleen F. Carlson, M.S., Ph.D., HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System (R&D 66), 3710 SW US Veterans Hospital Road, Portland, OR 97239; and Oregon Health and Science University - Portland State University School of Public Health, Portland, OR; e-mail: [email protected].Search for more papers by this authorTess A. Gilbert M.H.S.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Search for more papers by this authorBenjamin J. Morasco Ph.D.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Department of Psychiatry, Oregon Health and Science University, Portland, OR
Search for more papers by this authorDagan Wright Ph.D., M.S.P.H.
Oregon Health and Science University - Portland State University School of Public Health, Portland, OR
OCHIN, Portland, OR
Search for more papers by this authorJoshua Van Otterloo M.S.P.H.
Prescription Drug Monitoring Program, Public Health Division, Oregon Health Authority, Portland, OR
Search for more papers by this authorAldona Herrndorf M.P.H.
HSR&D Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR
Search for more papers by this authorLawrence J. Cook M.Stat., Ph.D.
Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT
Search for more papers by this authorAbstract
Objective
To examine the prevalence of concurrent Veterans Health Administration (VA) and non-VA prescriptions for opioids and sedative-hypnotic medications among post-9/11 veterans in Oregon.
Data Sources
VA health care and prescription data were probabilistically linked with Oregon Prescription Drug Monitoring Program (PDMP) data.
Study Design
This retrospective cohort study examined concurrent prescriptions among n = 19,959 post-9/11 veterans, by year (2014–2016) and by patient demographic and clinical characteristics. Veterans were included in the cohort for years in which they received VA outpatient care; those receiving hospice or palliative care were excluded. Concurrent prescriptions were defined as ≥1 days of overlap between outpatient prescriptions for opioids and/or sedative-hypnotics (categorized as benzodiazepines vs. non-benzodiazepines).
Principal Findings
Among 5,882 veterans who filled opioid or sedative-hypnotic prescriptions at VA pharmacies, 1,036 (17.6 percent) filled concurrent prescriptions from non-VA pharmacies. Within drug class, 15.1, 8.8, and 4.6 percent received concurrent VA and non-VA opioids, benzodiazepines, and non-benzodiazepines, respectively. Veteran demographics and clinical diagnoses were associated with the likelihood of concurrent prescriptions, as was enrollment in the Veterans Choice Program.
Conclusions
A considerable proportion of post-9/11 veterans receiving VA care in Oregon filled concurrent prescriptions for opioids and sedative-hypnotics. Fragmentation of care may contribute to prescription drug overdose risk among veterans.
Supporting Information
Filename | Description |
---|---|
hesr13025-sup-0001-AppendixSA1.pdfPDF document, 1.3 MB | Appendix SA1: Author Matrix. |
hesr13025-sup-0002-AppendixSA2.docxWord document, 27.5 KB | Appendix SA2: Characteristics of n = 19,959 Post-9/11 Veteran VA Outpatient Service Users in Oregon, by Receipt of VA Opioid or Sedative-Hypnotic Prescriptions. |
hesr13025-sup-0003-AppendixSA3.xlsxMS Excel, 175.1 KB | Appendix SA3: International Classification of Diseases—9th Revision—Clinical Modification Codes Used to Identify Veterans’ Diagnoses of Interest. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- Abrahamsson, T., J. Berge, A. Öjehagen, and A. Håkansson. 2017. “Benzodiazepine, z-Drug and Pregabalin Prescriptions and Mortality among Patients in Opioid Maintenance Treatment – A Nation-Wide Register-Based Open Cohort Study.” Drug and Alcohol Dependence 174: 58–64.
- Ali, M. M., W. N. Dowd, T. Classen, R. Mutter, and S. P. Novak. 2017. “Prescription Drug Monitoring Programs, Nonmedical use of Prescription Drugs, and Heroin use: Evidence from the National Survey of Drug Use and Health.” Addictive Behaviors 69: 65–77.
- Bao, Y., Y. Pan, A. Taylor, S. Radakrishnan, F. Luo, H. A. Pincus, and B. R. Schackman. 2016. “Prescription Drug Monitoring Programs are Associated with Sustained Reductions in Opioid Prescribing by Physicians.” Health Affairs 35 (6): 1045–51.
- Basham, C., L. M. Denneson, L. Millet, X. Shen, J. Duckart, and S. K. Dobscha. 2011. “Characteristics and VA Health Care Utilization of U.S. Veterans Who Completed Suicide in Oregon between 2000 and 2005.” Suicide and Life Threatening Behavior 41 (3): 287–96.
- Becker, W. C., B. T. Fenton, C. A. Brandt, E. L. Doyle, J. Francis, J. L. Goulet, B. A. Moore, V. Torrise, R. D. Kerns, and P. W. Kreiner. 2017. “Multiple Sources of Prescription Payment and Risky Opioid Therapy among Veterans.” Medical Care 55: S33–6.
- Bohnert, A. S., M. A. Ilgen, S. Galea, J. F. McCarthy, and F. C. Blow. 2011. “Accidental Poisoning Mortality among Patients in the Department of Veterans Affairs Health System.” Medical Care 49 (4): 393–6.
- Brandeis University, Heller School for Social Policy and Management, Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC). 2016. “ PDMP Prescriber Use Mandates: Characteristics, Current Status, and Outcomes in Selected States” [accessed on April 30, 2018]. Available at http://www.pdmpassist.org/pdf/Resources/Briefing_on_mandates_3rd_revision_A.pdf
- Brandeis University, Heller School for Social Policy and Management, Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC). 2017. “ State Profiles” [accessed on April 30, 2018]. Available at http://www.pdmpassist.org/content/state-profiles
- Brandeis University, Heller School for Social Policy and Management, Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC). 2018a. “ PDMP Mandatory Enrollment of Providers and Dispensers” [accessed on April 30, 2018]. Available at http://www.pdmpassist.org/pdf/Mandatory_Enrollment_20180417a.pdf
- Brandeis University, Heller School for Social Policy and Management, Prescription Drug Monitoring Program Training and Technical Assistance Center (PMDP TTAC). 2018b. “ PDMP Mandatory Query by Providers and Dispensers” [accessed on April 30, 2018]. Available at http://www.pdmpassist.org/pdf/Mandatory_Query_20180319.pdf
- Cifu, D. X., B. C. Taylor, W. F. Carne, F. William, D. Bidelspach, N. A. Sayer, J. Scholten, and E. H. Campbell. 2013. “Traumatic Brain Injury, Posttraumatic Stress Disorder, and Pain Diagnoses in OIF/OEF/OND Veterans.” Journal of Rehabilitation Research & Development 50 (9): 1169–76.
- Cook, L. J., L. M. Olson, and J. M. Dean. 2001. “Probabilistic Record Linkage: Relationships between File Sizes, Identifiers and Match Weights.” Methods in Inferential Medicine 40 (3): 196–203.
- Dowell, D., T. M. Haegerich, and R. Chou. 2016. “CDC Guideline for Prescribing Opioids for Chronic Pain – United States, 2016.” Morbidity and Mortality Weekly Report 65 (1): 1–49.
- Fellegi, I. P., and A. B. Sunter. 1969. “A Theory for Record Linkage.” Journal of the American Statistical Association 64 (328): 1183–210.
- Finklea, K. M., L. N. Sacco, and E. Bagalman. 2013. “ Prescription Drug Monitoring Programs” Congressional Research Service [accessed on April 30, 2018]. Available at https://fas.org/sgp/crs/misc/R42593.pdf
- Garg, R. K., D. Fulton-Kehoe, and G. M. Franklin. 2017. “Patterns of Opioid Use and Risk of Opioid Overdose Death among Medicaid Patients.” Medical Care 55 (7): 661–8.
- Gellad, W. F., C. B. Good, and D. J. Shulkin. 2017. “Addressing the Opioid Epidemic in the United States: Lessons from the Department of Veterans Affairs.” Journal of the American Medical Association Internal Medicine 177 (5): 611–2.
- Greenland, S., J. Pearl, and J. M. Robins. 1999. “Causal Diagrams for Epidemiologic Research.” Epidemiology 10 (1): 37–48.
- Griggs, C. A., S. G. Weiner, and J. A. Feldman. 2015. “Prescription Drug Monitoring Programs: Examining Limitations and Future Approaches.” Western Journal of Emergency Medicine 16 (1): 67–70.
- Hernán, M. A., S. Hernández-Díaz, M. M. Werler, and A. A. Mitchell. 2002. “Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology.” American Journal of Epidemiology 155 (2): 176–84.
- Hudson, T. J., J. T. Painter, B. C. Martin, M. A. Austen, J. S. Williams, J. C. Fortney, M. D. Sullivan, and M. J. Edlund. 2017. “Pharmacoepidemiologic Analyses of Opioid use among OEF/OIF/OND Veterans.” Pain 158 (6): 1039–45.
- Hynes, D. M., K. Koelling, K. Stroupe, A. Noreen, K. Mallin, M. Sohn, F. M. Weaver, L. Manheim, and L. Kok. 2007. “Veterans’ Access to and Use of Medicare and Veterans Affairs Health Care.” Medical Care 45 (3): 214–23.
- Jaro, M. A. 1995. “Probabilistic Linkage of Large Public Health Data Files.” Statistics in Medicine 14 (5–7): 491–8.
- Jones, J. D., S. Mogali, and S. D. Comer. 2012. “Polydrug Abuse: A Review of Opioid and Benzodiazepine Combination Use.” Drug and Alcohol Dependence 125 (1–2): 8–18.
- Kane, W. G., D. A. Wright, R. Fu, and K. F. Carlson. 2014. “Racial/Ethnic and Insurance Status Disparities in Discharge to Posthospitalization Care for Patients with Traumatic Brain Injury.” Journal of Head Trauma Rehabilitation 29 (6): E10–7.
- Kizer, K. W., and R. A. Dudley. 2009. “Extreme Makeover: Transformation of the Veterans Health Care System.” Annual Review of Public Health 30: 313–39.
- Leonhard, M. J., D. A. Wright, R. Fu, D. P. Lehrfeld, and K. F. Carlson. 2015. “Urban/Rural Disparities in Oregon Pediatric Traumatic Brain Injury.” Injury Epidemiology 2 (1): 32.
10.1186/s40621-015-0063-2 Google Scholar
- Lin, L. A., A. S. B. Bohnert, R. D. Kerns, M. A. Clay, D. Ganoczy, and M. A. Ilgen. 2017. “Impact of the Opioid Safety Initiative on Opioid-Related Prescribing in Veterans.” Pain 158 (5): 833–9.
- Macey, T. A., B. J. Morasco, J. P. Duckart, and S. K. Dobscha. 2011. “Patterns and Correlates of Prescription Opioid Use in OEF/OIF Veterans with Chronic Non-Cancer Pain.” Pain Medicine 12 (10): 1502–9.
- National Guard of Oregon. 2003. “ Oregon Sentinel: The Official Newsletter of the Oregon National Guard” [accessed April 30, 2018]. Available at http://www.oregon.gov/OMD/AGPA/docs/sentinel/winter03.pdf
- Oregon Health Authority, Division of Public Health. 2017. “ Oregon Prescription Drug Monitoring Program. 2016 Annual Report to the PDMP Advisory Commission” [accessed on April 30, 2018]. Available at http://www.orpdmp.com/orpdmpfiles/PDF_Files/Reports/PDMP_AC_AnnualReport_2016.pdf
- Oregon Heatlh Authority. 2018. “ Oregon Prescription Drug Monitoring Program” [accessed April 30, 2018]. Available at http://www.orpdmp.com/
- Patrick, S. W., C. E. Fry, T. F. Jones, and M. B. Buntin. 2016. “Implementation of Prescription Drug Monitoring Programs Associated with Reductions in Opioid-Related Death Rates.” Health Affairs 35 (7): 1324–32.
- Quinn, P. D., K. Hur, Z. Chang, E. E. Krebs, M. J. Bair, E. L. Scott, M. E. Rickert, R. D. Gibbons, K. Kroenke, and B. M. D'Onofrio. 2017. “Incident and Long-Term Opioid Therapy among Patients with Psychiatric Conditions and Medications: A National Study of Commercial Health Care Claims.” Pain 158 (1): 140–8.
- Seal, K. H., Y. Shi, G. Cohen, B. E. Cohen, S. Maguen, E. E. Krebs, and T. C. Neylan. 2012. “Association of Mental Health Disorders with Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan.” Journal of the American Medical Association 307 (9): 940–7.
- Shen, Y., A. Hendricks, S. Zhang, and L. E. Kazis. 2003. “VHA Enrollees’ Health Care Coverage and Use of Care.” Medical Care Research and Review 60 (2): 253–67.
- State of Oregon, 75th Oregon Legislative Assembly. 2009. “ Senate Bill 355, an Act Relating to an Electronic Prescription Monitoring Program; Appropriating Money; Limiting Expenditures” [accessed April 30, 2018]. Available at https://olis.leg.state.or.us/liz/2009R1/Downloads/MeasureDocument/SB355/Introduced
- Suda, K. J., B. M. Smith, L. Bailey, W. F. Gellad, Z. Huo, M. Burk, F. Cunningham, and K. T. Stroupe. 2017. “Opioid Dispensing and Overlap in Veterans with Non-Cancer Pain Eligible for Medicare Part D.” Journal of the American Pharmacists Association 57: 333–40.
- Sun, E. C., A. Dixit, K. Humphreys, B. D. Darnall, L. C. Baker, and S. Mackey. 2017. “Association Between Concurrent use of Prescription Opioids and Benzodiazepines and Overdose: Retrospective Analysis.” British Medical Journal 356: j760.
- Taylor, B. C., E. M. Hagel, K. F. Carlson, D. X. Cifu, A. Cutting, D. E. Bidelspach, and N. A. Sayer. 2012. “Prevalence and Costs of Co-Occurring Traumatic Brain Injury with and without Psychiatric Disturbance and Pain among Afghanistan and Iraq War Veteran VA Users.” Medical Care 50 (4): 342–6.
- US Centers for Disease Control and Prevention, National Center for Health Statistics. 2017a. “ Multiple Cause of Death 1999–2016.” CDC WONDER Online Database, Multiple Cause of Death Files, 1999–2016 [accessed on April 30, 2018]. Available at http://wonder.cdc.gov/mcd-icd10.html
- US Centers for Disease Control and Prevention, National Center for Health Statistics. 2017b. “ International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)” [accessed April 30, 2018]. Available at https://www.cdc.gov/nchs/icd/icd10cm.htm#FY%202018%20release%20of%20ICD-10-CM
- US Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. 2016. “ CDC Compilation of Benzodiazepines, Muscle Relaxants, Stimulants, Zolpidem, and Opioid Analgesics with Oral Morphine Milligram Equivalent Conversion Factors, 2016 Version” [accessed on April 30, 2018]. Available at http://www.pdmpassist.org/pdf/Conversion%20Reference%20Table.xlsx
- US Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. 2017. “ Data-Driven Prevention Initiative (DDPI)” [accessed on April 30, 2018]. Available at https://www.cdc.gov/drugoverdose/foa/ddpi.html
- US Centers for Medicaid & Medicare Services. 2016. “ 2017 ICD-10-CM and GEMS” [accessed on April 30, 2018]. Available at https://www.cms.gov/Medicare/Coding/ICD10/2017-ICD-10-CM-and-GEMs.html
- US Department of Agriculture, Economic Research Service. 2016. “ Documentation: 2010 Rural-Urban Commuting Area (RUCA) Codes” [accessed on April 30, 2018]. Available at https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/documentation.aspx
- US Department of Health and Human Services. 2009. “HIPAA Administrative Simplification: Modifications to Medical Data Code Set Standards to Adopt ICD-10-CM and ICD-10-PCS.” Federal Register 74 (11): 3328–62.
- US Department of Veterans Affairs. 2009. “Privacy Act; Systems of Records.” Federal Register 74 (142): 37093–6.
- US Department of Veterans Affairs. 2017a. “ Veterans Health Administration” [accessed on April 30, 2018]. Available at https://www.va.gov/health/
- US Department of Veterans Affairs. 2018a. “ Budget in Brief – 2019” [accessed on April 30, 2018]. Available at https://www.va.gov/budget/docs/summary/fy2019VAbudgetInBrief.pdf
- US Department of Veterans Affairs. 2018b. 172VA10P2: VHA Corporate Data Warehouse – VA. 79 FR 4377. Updated February 23, 2018.
- US Department of Veterans Affairs. 2017b. “ Veterans Choice Program” [accessed on April 30, 2018]. Available at https://www.va.gov/opa/choiceact/
- US Department of Veterans Affairs. 2018c. “ VA MISSION Act and New Veterans Community Care Program” [accessed on July 2, 2018]. Available at https://www.va.gov/COMMUNITYCARE/docs/pubfiles/factsheets/FactSheet_20-13.pdf
- US Department of Veterans Affairs. Office of Inspector General. 2017c. “ Healthcare Inspection: Opioid Prescribing to High-Risk Veterans Receiving VA Purchased Care” [accessed on April 30, 2018]. Available at https://www.va.gov/oig/pubs/VAOIG-17-01846-316.pdf
- US Department of Veterans Affairs, Pharmacy Benefits Management Services. 2017d. “ VA National Formulary” [accessed on April 30, 2018]. Available at https://www.pbm.va.gov/nationalformulary.asp
- US Department of Veterans Affairs, Veterans Health Administration. 2016. “ VA Directive 1306: Querying State Prescription Drug Monitoring Programs” [accessed on April 30, 2018]. Available at https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=3283
- US Substance Abuse and Mental Health Services Administration. 2017. “ National Survey on Drug use and Health, the CBHSQ Report: State and Substate Estimates of Nonmedical use of Prescription Pain Relievers” [accessed April 30, 2018]. Available at https://www.samhsa.gov/data/sites/default/files/report_3187/ShortReport-3187.html
- Westanmo, A. P., P. Marshall, E. Jones, K. Burns, and E. E. Krebs. 2015. “Opioid Dose Reduction in a VA Health Care System – Implementation of a Primary Care Population-Level Initative.” Pain Medicine 16 (5): 1019–26.
- Wolinsky, F. D., T. R. Miller, H. An, P. R. Brezinski, T. E. Vaughn, and G. E. Rosenthal. 2006. “Dual Use of Medicare and the Veterans Health Administration: Are There Adverse Health Outcomes?” BMC Health Services Research 6: 131.
- Yoon, J., and A. Chow. 2017. “Comparing Chronic Condition Rates Using ICD-9 and ICD-10 in VA Patients FY2014–2016.” BMC Health Services Research 17 (1): 572.